What if a workout routine could rival traditional cancer treatments?
At the ASCO Annual Meeting, a groundbreaking trial revealed that structured exercise reduced cancer recurrence by 28% and death by 37% in patients with stage III or high-risk stage II colon cancer. These patients, post-surgery and chemotherapy, followed a supervised physical activity plan tailored just for them—and the results rivaled some of the most effective oncology drugs.
The CHALLENGE trial, called a “new standard of care” by researchers, signals a paradigm shift: exercise isn’t just prevention—it may be a first-in-class anticancer therapy. The effect size? Comparable to, and sometimes exceeding, that of high-cost medical treatments.